COMPASS Pathways plc (CMPS) Financial Analysis & Valuation | Quarter Chart
COMPASS Pathways plc (CMPS)
CMPSPrice: $5.41
Fair Value: 🔒
🔒score
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the ... more
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and th... more
Description
Shares
| Market Cap | $519.78M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Care Facilities |
| Country | GB | CEO | Kabir Kumar Nath |
| IPO Date | 2020-09-18 | CAGR | — |
| Employees | 166 | Website | compasspathways.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
CMPS chart loading...
Fundamentals
Technicals
| Enterprise Value | $517.41M | P/E Ratio | -2.59 |
| Forward P/E | -4.63 | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | -9.58 |
| P/CF Ratio | -3.22 | P/FCF Ratio | -3.31 |
| EPS | $-2.72 | EPS Growth 1Y | 34.35% |
| EPS Growth 3Y | 43.06% | EPS Growth 5Y | 64.36% |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | -3.36% | ROA | -1.37% |
| ROCE | 4.78% | Current Ratio | 0.77 |
| Quick Ratio | 0.77 | Cash Ratio | 0.6 |
| Debt/Equity | -0.4 | Interest Coverage | -39.71 |
| Altman Z Score | -8.28 | Piotroski Score | 2 |